- 产品概述
- STR鉴定
- 参考文献
- 相关产品推荐
产品概述
名称 | MDA-MB-231(人乳腺癌细胞)(DMEM) (STR鉴定正确) |
别称 | MDA-MB 231; MDA.MB.231; MDA MB 231; MDA MB231; MDA Mb231; MDA-MB231; MDAMB-231; MDAMB231; MDA-231; MDA231; MB231; MD Anderson-Metastatic Breast-231 |
背景描述 | MDA-MB-231来自患有转移乳腺腺癌的51岁女病人的胸水。 在裸鼠和ALS处理的BALB/c小鼠中,它能形成低分化腺癌(III级)。细胞表达WNT7B癌基因。 |
种属 | 人类 |
年龄(性别) | 女性,51岁 |
组织来源 | 乳腺腺癌,转移性胸膜渗出液 |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 乳腺癌细胞 |
生物安全等级 | 1 |
生长培养基 | DMEM+10% FBS+1% P/S |
推荐传代比例 | 1:2-1:4 |
推荐换液频率 | 2~3次/周 |
倍增时间 | ~32-42小时 |
冻存条件 | 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮 |
培养条件 | 气相:空气,95%;CO2,5% 温度:37℃ |
致瘤性 | Yes, in ALS treated BALB/c mice, forms poorly differentiated adenocarcinoma (grade III).Yes, in nude mice, forms poorly differentiated adenocarcinoma (grade III). |
受体表达情况 | epidermal growth factor (EGF), expressed;transforming growth factor alpha (TGF alpha), expressed |
保藏机构 | ATCC; CRL-12532ATCC; HTB-26 ATCC; CRM-HTB-26 BCRC; 60425 BCRJ; 0164 DSMZ; ACC-732 ECACC; 92020424 |
STR鉴定
-
STR位点信息
Amelogenin X,X CSF1PO 12,13 D2S1338 20,21 D3S1358 16,16 D5S818 12,12 D7S820 8,9 D8S1179 13,13 D13S317 13,13 D16S539 12,12 D18S51 11,16 D19S433 11,14 D21S11 33.2,33.2 FGA 22,23 PentaD 11,14 PentaE 11,11 TH01 7,9.3 TPOX 8,9 vWA 15,18 D6S1043 18,18 D12S391 17,18 D2S441 14,15 -
STR鉴定图
参考文献
-
Intrinsic bioactivity of black phosphorus nanomaterials on mitotic centrosome destabilization through suppression of PLK1 kinase(2021/08/05)
作者:Ximing Shao, Zhihao Ding, Wenhua Zhou
期刊:Nature Nanotechnology
DOI:10.1038/s41565-021-00952-x
影响因子 :40.523
引用产品:CL-0016 CL-0101 CL-0103 CL-0150A CL-0150B CL-0236 CL-0238
-
Mitochondria-targeted magnetic gold nanoheterostructure for multi-modal imaging guided photothermal and photodynamic therapy of triple-negative breast cancer(2020/07/24)
作者:Bo Li, Qian Zhou, Haiyang Wang
期刊:Chemical Engineering Journal
DOI:10.1016/j.cej.2020.126364
影响因子 :16.744
引用产品:CL-0150A CL-0150B
-
MoS2 Quantum Dot@Polyaniline Inorganic–Organic Nanohybrids for in Vivo Dual-Modal Imaging Guided Synergistic Photothermal/Radiation Therapy(2016/09/07)
作者:Jinping Wang, Xiaoxiao Tan, Xiaojuan Pang
期刊:ACS Applied Materials & Interfaces
DOI:10.1021/acsami.6b08391
影响因子 :10.3830
引用产品:CL-0016 CL-0101 CL-0103 CL-0150A CL-0150B CL-0236 CL-0238
-
Phenotype-related drug sensitivity analysis of single CTCs for medicine evaluation(2020/08/10)
作者:Haimeng Pei, Mei Yu, Defang Dong
期刊:Chemical Science
DOI:10.1039/C9SC05566E
影响因子 :9.969
引用产品:CL-0149 CL-0150A CL-0150B
-
Up-regulated circBACH2 contributes to cell proliferation, invasion, and migration of triple-negative breast cancer(2021/4/19)
作者:Xinxing Wang, Bingjian Xue, Yujie Zhang
期刊:Cell Death & Disease
DOI:10.1038/s41419-021-03684-x
影响因子 :9.685
引用产品:CL-0040 CL-0041 CL-0149 CL-0150A CL-0150B CL-0152A CL-0152B CL-0290A CL-0290B CL-0525
-
MCPIP1-mediated NFIC alternative splicing inhibits proliferation of triple-negative breast cancer via cyclin D1-Rb-E2F1 axis(2021/04/06)
作者:Fengxia Chen, Qingqing Wang, Xiaoyan Yu
期刊:Cell Death & Disease
DOI:10.1038/s41419-021-03661-4
影响因子 :9.685
引用产品:CL-0005 CL-0041 CL-0114 CL-0150A CL-0150B CL-0380 CL-0525 PM150312B
-
Simultaneous Fluorescence Visualization of Epithelial-Mesenchymal Transition and Apoptosis Processes in Tumor Cells for Evaluating the Impact of Epithelial-Mesenchymal Transition on Drug Efficacy(2018/09/18)
作者:Mingming Luan, Jinjie Chang, Wei Pan
期刊:Anal Chem
DOI:10.1021/acs.analchem.8b02494
影响因子 :8.008
引用产品:CL-0150A CL-0150B CL-0184 CL-0525
-
A self-assembled RNA-triple helix hydrogel drug delivery system targeting triple-negative breast cancer(2019/11/08)
作者:Lairong Ding, Junwei Li, Changrong Wu
期刊:Journal of Materials Chemistry B
DOI:10.1039/C9TB01610D
影响因子 :7.571
引用产品:CL-0150A CL-0150B
-
Assessment of 2-allyl-4,5-dimethoxyphenol safety and attractiveness to mature males of Bactrocera dorsalis (Hendel)(2021/08/04)
作者:Shuzhen Deng, Xinyang Li, Ziming Wang
期刊:Ecotoxicology And Environmental Safety
DOI:10.1016/j.ecoenv.2021.112567
影响因子 :7.129
引用产品:CL-0037 CL-0106 CL-0150A CL-0150B
-
A Combined Self-Assembled Drug Delivery for Effective Anti-Breast Cancer Therapy(2021/03/23)
作者:Hairong Wang, Yawen Zhang, Xiangle Zeng
期刊:International Journal of Nanomedicine
DOI:10.2147/IJN.S299681
影响因子 :7.0330
引用产品:CL-0149 CL-0150A CL-0150B
-
Therapeutic Effect of Doxorubicin-Chlorin E6-Loaded Mesoporous Silica Nanoparticles Combined with Ultrasound on Triple-Negative Breast Cancer(2020/04/21)
作者:Peng Xu, Jia Yao, Zhen Li
期刊:International Journal of Nanomedicine
DOI:10.2147/IJN.S243037
影响因子 :7.0330
引用产品:CL-0150A CL-0150B
-
Weighted gene correlation network analysis identifies RSAD2, HERC5, and CCL8 as prognostic candidates for breast cancer(2019/06/21)
作者:Jianing Tang, Qian Yang, Qiuxia Cui
期刊:Journal Of Cellular Physiology
DOI:10.1002/jcp.28980
影响因子 :6.513
引用产品:CL-0150A CL-0150B
-
Co-delivery of epirubicin and paclitaxel using an estrone-targeted PEGylated liposomal nanoparticle for breast cancer(2020/01/05)
作者:Huan Tang, Jinglin Chen, Lin Wang
期刊:International Journal of Pharmaceutics
DOI:10.1016/j.ijpharm.2019.118806
影响因子 :6.510
引用产品:CL-0150A CL-0150B
-
CircFBXL5 promotes the 5-FU resistance of breast cancer via modulating miR-216b/HMGA2 axis(2021/07/19)
作者:Mingzhi Zhu, Yanyan Wang, Fang Wang
期刊:Cancer Cell International
DOI:10.1186/s12935-021-02088-3
影响因子 :6.429
引用产品:CL-0150A CL-0150B CL-0152A CL-0152B CL-0525
-
Ribociclib (LEE011) suppresses cell proliferation and induces apoptosis of MDA-MB-231 by inhibiting CDK4/6-cyclin D-Rb-E2F pathway(2019/10/07)
作者:Tianqi Li, Yudi Xiong, Qingqing Wang
期刊:Artificial Cells Nanomedicine and Biotechnology
DOI:10.1080/21691401.2019.1670670
影响因子 :6.355
引用产品:CL-0150A CL-0150B CL-0525
-
Enzymatic rhamnosylation of anticancer drugs by an α-l-rhamnosidase from Alternaria sp. L1 for cancer-targeting and enzyme-activated prodrug therapy(2019/08/08)
作者:Li Xu , Xiaohong Liu , Yinping Li
期刊:Applied Microbiology And Biotechnology
DOI:10.1007/s00253-019-10011-0
影响因子 :5.560
引用产品:CL-0150A CL-0150B CL-0525
-
Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer(2021/10/29)
作者:Wenqing Tang, Fangshi Xu, Meng Zhao
期刊:Bmc Cancer
DOI:10.1186/s12885-021-08892-4
影响因子 :4.638
引用产品:CL-0149 CL-0150A CL-0150B CL-0525
-
Possible involvement of TGF‑β‑SMAD‑mediated epithelial‑mesenchymal transition in pro‑metastatic property of PAX6(2020/06/11)
作者:Meng Jin, Daili Gao, Rongchun Wang
期刊:Oncology Reports
DOI:10.3892/or.2020.7644
影响因子 :4.136
引用产品:CL-0149 CL-0150A CL-0150B
-
Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell(2019/08/14)
作者:Mingjiang Yao, Xiaodi Fan, Bo Yuan
期刊:BMC Complementary and Alternative Medicine volume
DOI:10.1186/s12906-019-2615-4
影响因子 :3.6590
引用产品:CL-0150A CL-0150B
-
Overexpression of HOXD8 inhibits the proliferation, migration and invasion of breast cancer cells by downregulating ILP2 expression(2021/7/15)
作者:Xiaoyun Wen,Yu Chen, Xiansong Fang
期刊:Experimental and Therapeutic Medicine
DOI:10.3892/etm.2021.10439
影响因子 :2.7510
引用产品:CL-0149 CL-0150B CL-0211 CL-0525
-
The Antitumor Potential of Extract of the Oak Bracket Medicinal Mushroom Inonotus baumii in SMMC-7721 Tumor Cells(2019/09/22)
作者:Yue Yang, Pingya He
期刊:Evidence-Based Complementary and Alternative Medicine
DOI:10.1155/2019/1242784
影响因子 :2.650
引用产品:CL-0150A CL-0150B CL-0215
相关产品推荐
- NCI-H1650 (人非小细胞肺癌细胞) (STR鉴定正确)
- MDA-MB-436 (人乳腺癌细胞) (STR鉴定正确)
- Ramos [RA 1] (人B淋巴细胞瘤细胞) (STR鉴定正确)